{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:20:25Z","timestamp":1758979225191},"reference-count":141,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.intimp.2005.11.018","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T18:00:20Z","timestamp":1134669620000},"page":"557-578","source":"Crossref","is-referenced-by-count":33,"title":["Use of intravenous immunoglobulin therapy in autoimmune blistering diseases"],"prefix":"10.1016","volume":"6","author":[{"given":"A. Razzaque","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2005.11.018_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.018_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0025-7125(05)70415-6","article-title":"The blistering diseases","volume":"82","author":"Scott","year":"1998","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.intimp.2005.11.018_bib3","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0190-9622(88)70128-0","article-title":"Pemphigus","volume":"18","author":"Korman","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0190-9622(81)70076-8","article-title":"Epidermolysis bullosa acquisita: a heterogeneous disease","volume":"5","author":"Palestine","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.284.3.350","article-title":"Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations","volume":"284","author":"Yancey","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2005.11.018_bib6","doi-asserted-by":"crossref","first-page":"987-01","DOI":"10.1016\/0190-9622(91)70159-Y","article-title":"Cicatricial pemphigoid","volume":"24","author":"Ahmed","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0738-081X(00)00190-5","article-title":"Therapy of pemphigus","volume":"19","author":"Toth","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0733-8635(05)70006-1","article-title":"Immunosuppressive agents in dermatology. An update","volume":"16","author":"Dutz","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.intimp.2005.11.018_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archderm.138.3.385","article-title":"A systematic review of treatments for bullous pemphigoid","volume":"138","author":"Khumalo","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archderm.138.3.380","article-title":"Interventions for mucous membrane pemphigoid\/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review","volume":"138","author":"Kirtschig","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1067\/mjd.2001.113693","article-title":"Emerging treatment for epidermolysis bullosa acquisita","volume":"44","author":"Engineer","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/mjd.2001.119085","article-title":"Intravenous immune globulin: fighting antibodies with antibodies","volume":"45","author":"Dahl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0190-9622(89)80148-3","article-title":"High-dosage intravenous gamma globulin: therapeutic failure in pemphigus and pemphigoid","volume":"20","author":"Tappeiner","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(08)80783-9","article-title":"Effects of intravenous gamma globulin in pemphigus","volume":"22","author":"Humbert","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.1995.tb06952.x","article-title":"High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris","volume":"133","author":"Messer","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.1995.tb02631.x","article-title":"Adjuvant high-dose intravenous immunoglobulins in the treatment of pemphigus and bullous pemphigoid: experience in six patients","volume":"133","author":"Beckers","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2133.1996.tb03624.x","article-title":"Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy","volume":"135","author":"Bewley","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib18","first-page":"852","article-title":"Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy","volume":"135","author":"Wever","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1365-2133.1998.02297.x","article-title":"Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy","volume":"138","author":"Colonna","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2133.1999.02817.x","article-title":"High-dose intravenous immunoglobulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases","volume":"140","author":"Harman","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0190-9622(99)70516-5","article-title":"Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris","volume":"40","author":"Jolles","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2001.116339","article-title":"Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archderm.138.9.1158","article-title":"Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris","volume":"138","author":"Sami","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2249.2001.01637.x","article-title":"Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up, and treatment responses","volume":"125","author":"Sami","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2005.11.018_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mjd.2002.116338","article-title":"Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy","volume":"46","author":"Ahmed","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib26","first-page":"174","article-title":"Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus","volume":"12","author":"Sami","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1999.03071.x","article-title":"Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins","volume":"141","author":"Toth","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/0003-4819-103-6-965_1","article-title":"Bullous pemphigoid and intravenous gammaglobulin","volume":"103","author":"Godard","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.intimp.2005.11.018_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mjd.2001.116337","article-title":"Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib30","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study","volume":"106","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.intimp.2005.11.018_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2133.1997.tb03770.x","article-title":"Cicatricial pemphigoid treated with intravenous immunoglobulin","volume":"137","author":"Urcelay","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib32","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.137.9.1181","article-title":"Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid","volume":"137","author":"Ahmed","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clim.2001.5150","article-title":"Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid","volume":"102","author":"Sami","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2005.11.018_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1067\/mjd.2002.117860","article-title":"Cicatricial pemphigoid with circulation IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: beneficial effect of adjuvant therapy with high-dose intravenous immunoglobulin","volume":"46","author":"Leverkus","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2002.01942.x","article-title":"Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy long-term follow-up: influence of treatment on autoantibody titers to human alpha 6 integrin","volume":"129","author":"Sami","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2005.11.018_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0190-9622(93)70189-Z","article-title":"Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins","volume":"29","author":"Meier","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0190-9622(09)80064-9","article-title":"Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins","volume":"31","author":"Caldwell","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2133.1995.tb00735.x","article-title":"Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins","volume":"132","author":"Mohr","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0190-9622(97)80411-2","article-title":"Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita","volume":"36","author":"Kofler","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib40","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1046\/j.1365-2133.1998.2576m.x","article-title":"Severe refractory epidermolysis bullosa complicated by an esophageal stricture responding to intravenous immune globulin","volume":"139","author":"Harman","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2133.2000.03368.x","article-title":"Epidermolysis bullosa acquisita with ultraviolet radiation sensitivity","volume":"142","author":"Jappe","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1468-3083.2002.00386.x","article-title":"Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins","volume":"16","author":"Gourgiotou","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.intimp.2005.11.018_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1067\/mjd.2002.113682","article-title":"Epidermolysis bullosa acquisita and multiple myeloma","volume":"47","author":"Engineer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0190-9622(99)70504-9","article-title":"Linear IgA bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy","volume":"40","author":"Khan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib45","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2133.2000.03395.x","article-title":"High-dose intravenous immunoglobulin is also effective in linear IgA disease","volume":"142","author":"Kroiss","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib46","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0161-6420(00)00245-1","article-title":"Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy","volume":"1078","author":"Letko","year":"2000","journal-title":"Ophthalmol"},{"key":"10.1016\/j.intimp.2005.11.018_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2230.1998.00342.x","article-title":"A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporine","volume":"3","author":"Hern","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1532-5415.1998.tb01020.x","article-title":"Pemphigus vulgaris in older adults","volume":"461","author":"Tehranchi-Nia","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.intimp.2005.11.018_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0749-0690(03)00033-8","article-title":"Bullous diseases in the elderly","volume":"18","author":"Mutasim","year":"2002","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.intimp.2005.11.018_bib50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00008480-200208000-00012","article-title":"Pemphigus vulgaris in an adolescent","volume":"14","author":"Jun","year":"2002","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.intimp.2005.11.018_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mjd.2002.119647","article-title":"Nonendemic pemphigus foliaceus in children","volume":"46","author":"Metry","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1525-1470.1986.tb00651.x","article-title":"Childhood pemphigus foliaceus: case report and review of the literature","volume":"3","author":"Jones","year":"1986","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib53","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archderm.1980.01640330073017","article-title":"Pemphigus in Hartford County, Connecticut, from 1972 to 1977","volume":"1169","author":"Simon","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.intimp.2005.11.018_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-0960.1989.tb00405.x","article-title":"A five year retrospective study on pemphigus and pemphigoid","volume":"30","author":"Kyriakis","year":"1989","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.intimp.2005.11.018_bib56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2340\/0001555562491496","article-title":"Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978","volume":"62","author":"Hietanen","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.intimp.2005.11.018_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1440-0960.2001.00509.x","article-title":"Comparative study of pemphigus vulgaris and pemphigus foliaceus in Singapore","volume":"42","author":"Goon","year":"2001","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/1523-1747.ep12612836","article-title":"Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women","volume":"104","author":"Bastuji-Garin","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1523-1747.ep13070394","article-title":"Endemic pemphigus foliaceus (fogo selvagem): II. Current and historic epidemiologic studies","volume":"92","author":"Diaz","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0733-8635(18)30140-2","article-title":"Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo selvagem (wild fire)","volume":"12","author":"Sampaio","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.intimp.2005.11.018_bib61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-4362.1979.tb04683.x","article-title":"Pemphigus in El Salvador. An eight-year study (1970\u20131977)","volume":"18","author":"Hernandez-Perez","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib62","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib64","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib65","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004397-199603610-00007","article-title":"Cicatricial pemphigoid: diagnosis and treatment","volume":"36","author":"Nguyen","year":"1996","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.intimp.2005.11.018_bib67","first-page":"1518","article-title":"Epidermolysis bullosa acquisita (EBA) and esophageal webs: a new association","volume":"86","author":"Weinman","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.intimp.2005.11.018_bib68","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archderm.1997.03890450070008","article-title":"Epidermolysis bullosa acquisita in childhood","volume":"133","author":"Callot-Mellot","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib69","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.1977.01640110040004","article-title":"Oral pemphigus vulgaris. A report of ten cases","volume":"113","author":"Meurer","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib70","first-page":"682","article-title":"Autoantibodies in pemphigus vulgaris","volume":"8","author":"Beutner","year":"1965","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib71","first-page":"141","article-title":"Autoimmunity in chronic bullous skin diseases. Immunofluorescent demonstration of three types of antibodies to skin in sera of patients with pemphigus, bullous pemphigoid, and in other human sera","volume":"2","author":"Beutner","year":"1967","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2005.11.018_bib72","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000051540","article-title":"Autoimmunity to keratinocyte acetylcholine receptors in pemphigus","volume":"201","author":"Grando","year":"2000","journal-title":"Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/1523-1747.ep12546138","article-title":"The correlation between the antibody titers in sera of patients with pemphigus vulgaris and their clinical state","volume":"71","author":"Weissman","year":"1978","journal-title":"J Inv Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib74","doi-asserted-by":"crossref","first-page":"92-02","DOI":"10.1016\/S0923-1811(99)00016-X","article-title":"Autoimmunity against desmosomal cadherins in pemphigus","volume":"20","author":"Amagai","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2005.11.018_bib75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib76","first-page":"63","article-title":"Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1","volume":"4","author":"Hashimoto","year":"1995","journal-title":"Epithelial Cell Biol"},{"key":"10.1016\/j.intimp.2005.11.018_bib77","first-page":"54","article-title":"Bullous and cicatricial pemphigoid: clinical, histopathologic, and immunopathologic correlations","volume":"52","author":"Person","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.intimp.2005.11.018_bib78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/0001555561417421","article-title":"Clinical variations in bullous pemphigoid with respect to early symptoms","volume":"61","author":"Asbrink","year":"1981","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.intimp.2005.11.018_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0190-9622(81)70077-X","article-title":"Pemphigoid nodularis","volume":"5","author":"Yung","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1967.03120220053008","article-title":"Basement zone antibodies in bullous pemphigoid","volume":"200","author":"Jordan","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2005.11.018_bib81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/jid.1968.94","article-title":"The immunopathology of pemphigus and bullous pemphigoid","volume":"51","author":"Beutner","year":"1968","journal-title":"J Inv Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12259692","article-title":"Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin","volume":"82","author":"Gammon","year":"1984","journal-title":"J Inv Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib83","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archderm.1997.03890450048006","article-title":"Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses","volume":"133","author":"Ghohestani","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib84","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2005.11.018_bib85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1523-1747.ep12525707","article-title":"Some biochemical properties of pemphigoid antigen bound to the surface of dissociated epidermal basal cells","volume":"76","author":"Grekin","year":"1981","journal-title":"J Inv Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0923-1811(00)00149-3","article-title":"Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"26","author":"Amo","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2005.11.018_bib88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","article-title":"Cicatricial pemphigoid","volume":"25","author":"Ahmed","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib89","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/000348948809700511","article-title":"Upper aerodigestive tract manifestations of cicatricial pemphigoid","volume":"97","author":"Hanson","year":"1988","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.intimp.2005.11.018_bib90","first-page":"627","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol"},{"key":"10.1016\/j.intimp.2005.11.018_bib91","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archotol.1971.00770060546002","article-title":"Oral lesions of mucous membrane pemphigoid","volume":"93","author":"Shklar","year":"1971","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.intimp.2005.11.018_bib92","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0190-9622(82)70153-7","article-title":"Desquamate gingivitis: clinical, histopathologic, and therapeutic observations","volume":"7","author":"Rogers","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archderm.1972.01620110031007","article-title":"Cicatricial pemphigoid: immunofluorescent studies","volume":"106","author":"Bean","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12485162","article-title":"Immunopathology of cicatricial pemphigoid: studies of complement deposition","volume":"68","author":"Rogers","year":"1977","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib95","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archderm.1973.01620230060023","article-title":"Circulating antibodies in cicatricial pemphigoid","volume":"108","author":"Dantzig","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib96","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archderm.1996.03890340054009","article-title":"Immune-mediated subepithelial blistering diseases of the mucous membranes: improving the detection of circulating autoantibodies by the use of concentrated sera","volume":"132","author":"Korman","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","article-title":"The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid","volume":"118","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib98","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archderm.1994.01690120057008","article-title":"Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder","volume":"130","author":"Domloge-Hultsch","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib99","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543784.13.8.1019","article-title":"Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy","volume":"13","author":"Ahmed","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.intimp.2005.11.018_bib100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2004.04.010","article-title":"Profile of autoantibody to basement membrane zone proteins in patients with mucous membrane pemphigoid: long-term follow-up and influence of therapy","volume":"3","author":"Yeh","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2005.11.018_bib101","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0190-9622(84)80459-4","article-title":"Epidermolysis bullosa acquisita-a pemphigoid-like disease","volume":"11","author":"Gammon","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib102","first-page":"218","article-title":"Epidermolysis bullosa acquisita","volume":"7","author":"Gammon","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib103","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-Type VII collagen autoantibodies in epidermolysis acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib104","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","article-title":"Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita","volume":"310","author":"Woodley","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2005.11.018_bib105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0733-8635(05)70305-3","article-title":"New immunomodulating drugs in autoimmune blistering diseases","volume":"19","author":"Korman","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.intimp.2005.11.018_bib106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib107","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archderm.1972.01620140005001","article-title":"Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid","volume":"106","author":"Krain","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib108","doi-asserted-by":"crossref","first-page":"998-00","DOI":"10.1016\/S0190-9622(08)80651-2","article-title":"Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases","volume":"28","author":"Chaffins","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib109","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2133.1976.tb05168.x","article-title":"Pemphigus controlled by dapsone","volume":"94","author":"Piamphongsant","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/0003-4819-71-1-125","article-title":"Pemphigus vulgaris successfully treated with cyclophosphamide","volume":"71","author":"Ebringer","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.intimp.2005.11.018_bib111","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib112","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib113","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/archderm.1992.04530010064010","article-title":"Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide","volume":"128","author":"Pandya","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib114","first-page":"647","article-title":"Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris-preliminary report","volume":"62","author":"Rook","year":"1989","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.intimp.2005.11.018_bib115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archderm.1988.01670020054017","article-title":"Pemphigus vulgaris: combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine","volume":"124","author":"Fine","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib116","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1468-3083.2002.00413.x","article-title":"Dexamethasone pulse therapy in pemphigus","volume":"16","author":"Toth","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.intimp.2005.11.018_bib117","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000251283","article-title":"Bullous pemphigoid controlled by dapsone","volume":"152","author":"Piamphongsant","year":"1976","journal-title":"Dermatologica"},{"key":"10.1016\/j.intimp.2005.11.018_bib118","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archderm.1977.01640050070009","article-title":"Bullous pemphigoid responding to sulfapyridine and the sulfones","volume":"113","author":"Person","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib119","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archderm.1986.01660180076019","article-title":"The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report","volume":"122","author":"Berk","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0190-9622(90)70111-T","article-title":"The use of chlorambucil in the treatment of bullous pemphigoid","volume":"22","author":"Milligan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib121","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(97)80092-X","article-title":"Bullous pemphigoid treated with mycophenolate mofetil","volume":"349","author":"Bohm","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2005.11.018_bib122","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1365-2133.1997.tb01131.x","article-title":"Severe bullous pemphigoid responsive to pulsed intravenous dexamethasone and oral cyclophosphamide","volume":"137","author":"Dawe","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib123","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.1996.tb06329.x","article-title":"Successful treatment of bullous pemphigoid with pulse intravenous cyclophosphamide","volume":"134","author":"Itoh","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib124","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archderm.1984.01650450039014","article-title":"High-dose methylprednisolone in the treatment of bullous pemphigoid","volume":"120","author":"Siegel","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib125","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archderm.121.12.1484a","article-title":"Plasmapheresis therapy or bullous pemphigoid","volume":"121","author":"Goldberg","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib127","first-page":"201","article-title":"Dapsone therapy of cicatricial pemphigoid","volume":"7","author":"Rogers","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(01)00863-6","article-title":"The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.intimp.2005.11.018_bib129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70230-8","article-title":"Update on systemic glucocorticosteroids in dermatology","volume":"19","author":"Williams","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.intimp.2005.11.018_bib130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archderm.138.6.827","article-title":"Immunosuppression and skin cancer: pathogenic insights, therapeutic challenges, and opportunities of innovation","volume":"138","author":"Otley","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib131","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in PV","volume":"42","author":"Herbst","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib132","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","article-title":"Death in pemphigus","volume":"7","author":"Ahmed","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib133","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2133.1979.tb11881.x","article-title":"The events leading to the death of patients with pemphigus and pemphigoid","volume":"1010","author":"Savin","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib134","first-page":"251","article-title":"Nonendemic pemphigus foliaceus presenting as fatal bullous exfoliative erythroderma","volume":"67","author":"Nousari","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.intimp.2005.11.018_bib135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0190-9622(92)70085-T","article-title":"Lack of predictive factors for the clinical course of bullous pemphigoid","volume":"26","author":"Venning","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib136","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","article-title":"Treatment of pemphigus with intravenous immunoglobulin","volume":"47","author":"Bystryn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","article-title":"A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies","volume":"3","author":"Letko","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2005.11.018_bib138","first-page":"377","article-title":"Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris","volume":"4","author":"Sami","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib139","first-page":"1051","article-title":"From the consensus development group. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"8","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.134.1.80","article-title":"Dermatological uses of high-dose intravenous immunoglobulin","volume":"134","author":"Jolles","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.intimp.2005.11.018_bib141","unstructured":"FDA interim statement regarding immune globulin intravenous (IGIV). August 27, 2002. Available from: http:\/\/www.fda.gov\/cber\/infosheets\/igiv082702.htm. Accessed October 13, 2004."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905003164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905003164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:40:11Z","timestamp":1706816411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576905003164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1567576905003164"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2005.11.018","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}